Highlighted research studies
Testing a vaccine for glioblastomas
Our researchers are conducting clinical trials to study the interaction between brain tumors and the immune system. This information will allow the development of more effective therapeutic options for glioblastomas, the most common and lethal primary brain tumor. These studies take advantage of the cellular immune response by vaccination and also explore ways to elicit an antibody response.
New imaging advances
Researchers from Thayer School of Engineering and the Geisel School of Medicine at Dartmouth have worked together to spearhead new technology in navigational tools used in the operating room. The technologies developed allow for more precise and safe surgical procedures for patients with brain tumors. Studies using fluorescence to aid in surgical excision have allowed removal of tumor tissue that would have otherwise been left behind.
Mapping genetic signatures
Basic science researchers are taking advantage of brain tumor tissue banking to identify both prognostic and predictive biomarkers allowing more individualized treatment plans. These markers then guide the therapeutic approach.
As the only Academic Medical Center in New Hampshire, Dartmouth-Hitchcock Medical Center and the Dartmouth-Hitchcock Health System have many active trials that are enrolling patients across the system.
A clinical trial/study is research in which people can participate and is one of the final steps in the process to look for better ways to prevent, diagnose, or treat your condition. The purpose of a clinical trial/study is to research the effectiveness of a treatment, medication, experimental drug, or device. Many of the "standard treatments" that patients receive today were developed based on the results of previous clinical trials.
View the list of brain and nervous system clinical trials with which this cancer care program is currently involved. Consider joining a trial today, you could help change the future of medicine.